Active Ingredient History
Iron(II) sulfate (British English: iron(II) sulphate) or ferrous sulfate denotes a range of salts with the formula FeSO4·xH2O. These compounds exist most commonly as the heptahydrate (x = 7) but several values for x are known. The hydrated form is used medically to treat or prevent iron deficiency, and also for industrial applications. Known since ancient times as copperas and as green vitriol (vitriol is an archaic name for sulfate), the blue-green heptahydrate (hydrate with 7 molecules of water) is the most common form of this material. All the iron(II) sulfates dissolve in water to give the same aquo complex [Fe(H2O)6]2+, which has octahedral molecular geometry and is paramagnetic. The name copperas dates from times when the copper(II) sulfate was known as blue copperas, and perhaps in analogy, iron(II) and zinc sulfate were known respectively as green and white copperas. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abdominal Pain (Early Phase 1)
Anemia (Phase 4)
Anemia, Iron-Deficiency (Phase 4)
Angiodysplasia (Phase 2)
Autism Spectrum Disorder (Phase 2)
Cerebral Palsy (Phase 4)
Child Behavior Disorders (Phase 4)
Colitis, Ulcerative (Phase 4)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 4)
Constipation (Early Phase 1)
Critical Illness (Phase 2)
Crohn Disease (Phase 4)
Delivery, Obstetric (Phase 4)
Depression, Postpartum (Phase 2/Phase 3)
Diarrhea (Early Phase 1)
Dysbiosis (Phase 2)
Fatigue (Phase 4)
Gastric Antral Vascular Ectasia (Phase 2)
Healthy Volunteers (Phase 1)
Heartburn (Early Phase 1)
Heart Failure (Phase 3)
Heart Failure, Systolic (Phase 4)
Hemorrhage (Phase 2)
Hip Fractures (Phase 3)
Hypothyroidism (Phase 1)
Hypoxia (Early Phase 1)
Inflammation (Phase 4)
Inflammatory Bowel Diseases (Phase 2)
Intestinal Neoplasms (Phase 4)
Intestines (Phase 4)
Iron Deficiencies (Phase 4)
Kidney Failure, Chronic (Phase 4)
Leiomyoma (Phase 4)
Leukemia (Phase 3)
Lymphoma (Phase 3)
Lymphoproliferative Disorders (Phase 3)
Menorrhagia (Phase 4)
Multiple Myeloma (Phase 3)
Neoplasms (Phase 3)
Neurobehavioral Manifestations (Phase 4)
Osteoarthritis, Knee (Phase 4)
Postoperative Complications (Phase 4)
Precancerous Conditions (Phase 3)
Pregnancy (Phase 4)
Pregnancy Complications (Phase 4)
Puerperal Disorders (Phase 2/Phase 3)
Renal Insufficiency, Chronic (Phase 4)
Restless Legs Syndrome (Phase 4)
Sleep Disorders, Intrinsic (Phase 4)
Sleep Wake Disorders (Phase 4)
Thalidomide (Phase 2)
Uterine Diseases (Phase 4)
Uterine Hemorrhage (Phase 3)
Ventricular Dysfunction, Right (Early Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
